These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 23358478)

  • 41. [201 Tl myocardial scintigrams of hypertrophic cardiomyopathy--201 Tl uptake by the right ventricular myocardium].
    Miyanaga H; Adachi H; Sugihara H; Torii Y; Watanabe T; Katume H; Ijichi H
    Kaku Igaku; 1983 Apr; 20(3):329-33. PubMed ID: 6685200
    [No Abstract]   [Full Text] [Related]  

  • 42. [Abnormal thallium myocardial perfusion in hypertrophic cardiomyopathy: comparison with echocardiographic, hemodynamic, and serum enzyme findings].
    Nishimura T; Nagata S; Uehara T; Hayashida K; Kozuka T; Sakakibara H
    Kaku Igaku; 1987 Sep; 24(9):1365-76. PubMed ID: 3437578
    [No Abstract]   [Full Text] [Related]  

  • 43. Periprocedural complications and long-term outcome after alcohol septal ablation versus surgical myectomy in hypertrophic obstructive cardiomyopathy: a single-center experience.
    Steggerda RC; Damman K; Balt JC; Liebregts M; ten Berg JM; van den Berg MP
    JACC Cardiovasc Interv; 2014 Nov; 7(11):1227-34. PubMed ID: 25326737
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MRI of cardiac morphology and function after percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy.
    Amano Y; Takayama M; Amano M; Kumazaki T
    AJR Am J Roentgenol; 2004 Feb; 182(2):523-7. PubMed ID: 14736694
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy.
    Valeti US; Nishimura RA; Holmes DR; Araoz PA; Glockner JF; Breen JF; Ommen SR; Gersh BJ; Tajik AJ; Rihal CS; Schaff HV; Maron BJ
    J Am Coll Cardiol; 2007 Jan; 49(3):350-7. PubMed ID: 17239717
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Myocardial thallium 201 imaging in hypertrophic obstructive cardiomyopathy.
    Hanrath P; Mathey D; Montz R; Thiel U; Vorbringer H; Kupper W; Schneider C; Bleifeld W
    Eur Heart J; 1981 Jun; 2(3):177-85. PubMed ID: 7196835
    [No Abstract]   [Full Text] [Related]  

  • 47. Quantification of changes in septal strain after alcohol septal ablation in hypertrophic obstructive cardiomyopathy-cases from the three-dimensional speckle tracking echocardiographic MAGYAR-path study.
    Nemes A; Domsik P; Kalapos A; Gavallér H; Forster T; Sepp R
    Echocardiography; 2013 Oct; 30(9):E289-91. PubMed ID: 23808936
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The long-term outcomes of transcoronary ablation of septal hypertrophy compared to surgical myectomy in patients with symptomatic hypertrophic obstructive cardiomyopathy.
    Samardhi H; Walters DL; Raffel C; Rateesh S; Harley C; Burstow D; Pohlner P; Aroney C
    Catheter Cardiovasc Interv; 2014 Feb; 83(2):270-7. PubMed ID: 23873660
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Comparable effects of percutaneous transluminal septal myocardial ablation and subaortic ventriculotomy in treating patients with hypertrophic obstructive cardiomyopathy, an echocardiography follow-up study].
    Li J; Liu YL; He Q; Qiao SB; Feng W; Lü XZ; Zhu ZH; Ling Y; Wang JP
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Aug; 34(8):695-8. PubMed ID: 17081391
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Correlation of various types of perfusion defects with supraventricular and ventricular arrhythmias in hypertrophic cardiomyopathy].
    Doi Y; Yonezawa Y; Chikamori T; Hamashige N; Kuzume O; Takata J; Yamada M; Ozawa T
    J Cardiol; 1989 Dec; 19(4):1089-98. PubMed ID: 2486630
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Use of intraprocedural CT imaging to guide alcohol septal ablation. Combining complementary imaging modalities.
    Nagy C; Kimmelstiel C
    Catheter Cardiovasc Interv; 2012 Nov; 80(6):995-6. PubMed ID: 23166102
    [No Abstract]   [Full Text] [Related]  

  • 52. [Ventricular wall thickness evaluated by radionuclide cardiac imaging].
    Nakai K; Katsuragawa S; Usui Y; Matsushita K; Kawamura A; Takahashi H; Kato M; Takahashi T; Yanagisawa T
    J Cardiogr; 1983 Dec; 13(4):1060. PubMed ID: 6687231
    [No Abstract]   [Full Text] [Related]  

  • 53. Myocardial metabolic changes in hypertrophic cardiomyopathy.
    Tadamura E; Tamaki N; Matsumori A; Magata Y; Yonekura Y; Nohara R; Sasayama S; Yoshibayashi M; Kamiya T; Konishi J
    J Nucl Med; 1996 Apr; 37(4):572-7. PubMed ID: 8691242
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Washout rate in hypertrophic cardiomyopathy assessed by exercise myocardial scintigraphy].
    Genda A; Igarashi Y; Mizuno S; Sugihara N; Kita Y; Suematsu T; Shimizu M; Takeda R; Bunko H; Hisada K
    J Cardiogr; 1986 Dec; 16(4):893-905. PubMed ID: 3429906
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Safety and efficacy comparison of myocardial contrast enhancement-guided and angio-pressure-guided transcoronary ablation of septal hypertrophy for patients with hypertrophic obstructive cardiomyopathy].
    Gao YC; Li Y; Wu XS; Jia CQ; Jiang TY
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Jun; 35(6):540-3. PubMed ID: 17711715
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Decreased coronary reserve in patients with hypertrophic cardiomyopathy--a study using split dose thallium-201 dipyridamole myocardial imaging].
    Yamaguchi R
    Kokyu To Junkan; 1987 Jan; 35(1):97-103. PubMed ID: 3563138
    [No Abstract]   [Full Text] [Related]  

  • 57. [An autopsy case of cardiomyopathy demonstrated specific findings by thallium-201 myocardial scintigraphy].
    Matsuo T; Nishimura T; Uehara T; Hayashida K; Chiba H; Mitani I; Nagata S; Yutani C
    Kaku Igaku; 1988 Aug; 25(8):801-7. PubMed ID: 3193653
    [No Abstract]   [Full Text] [Related]  

  • 58. [Effects of atrial contribution on the two-beat left ventricular volume curve obtained by ECG-gated radionuclide angiocardiography].
    Kondo T; Hishida H; Negishi Y; Kaneko K; Kato Y; Kogame Y; Kiriyama T; Mizuno Y; Takeuchi A; Koike K
    J Cardiogr; 1982 Mar; 12(1):189-202. PubMed ID: 6889624
    [No Abstract]   [Full Text] [Related]  

  • 59. [Quantitation of regional and global cardiac performance by phase analysis using higher-order harmonics: (3) Comparison of hypertrophic heart disease and ischemic heart disease].
    Kodama S; Tamaki N; Mukai T; Yonekura Y; Minato K; Senda M; Konishi J; Torizuka K; Suzuki Y; Tamaki S
    Kaku Igaku; 1984 Apr; 21(4):331-40. PubMed ID: 6088868
    [No Abstract]   [Full Text] [Related]  

  • 60. Significant inducible perfusion abnormality in an asymptomatic patient with hypertrophic cardiomyopathy demonstrated by radionuclide myocardial perfusion imaging.
    Loong CY; Reyes E; Underwood SR
    Heart; 2003 Sep; 89(9):989. PubMed ID: 12923005
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.